by Xcellerant Ventures | Jan 23, 2026 | Portfolio Company News
Former ASU professor’s patented technology at the heart of FDA-cleared vital sign-checking medical device. Americans wait an average of 31 days to see a health care provider, a 22% increase since 2022. And while telehealth visits provide cost-effective and...
by Xcellerant Ventures | Jan 9, 2026 | Portfolio Company News
The consolidated entity will leverage AI and precision engineering to create a comprehensive ecosystem advancing drug delivery, home monitoring, and clinical intelligence. ROCHESTER, Minn., Jan. 9, 2026 /PRNewswire/ — Nanodropper, the leader in...
by Xcellerant Ventures | Nov 26, 2025 | Portfolio Company News
Phoenix, AZ (November 26, 2025): DeepLook Medical, a leader in visual enhancement technology for medical imaging, announced four strategic partnerships with Ikonopedia, Incepto, Pintail Strategic Advisors, and TestDynamics to advance its precision imaging...
by Xcellerant Ventures | Oct 27, 2025 | Portfolio Company News
DeepLook Medical Partners with Oxford NHS Hospitals to Launch AI Study for Dense Breast Cancer Detection Oxford UK and Phoenix, AZ, October 27, 2025: DeepLook Medical, a leader in visual enhancement technology to advance medical imaging, has announced the launch of...
by Xcellerant Ventures | Oct 9, 2025 | Xcellerant Ventures News
SCOTTSDALE, Ariz., Oct. 9, 2025 /PRNewswire/ — Xcellerant Ventures (XVC) today announced the launch of the Jetstream Venture Fund (Jetstream), an innovative interval fund recently declared effective by the SEC. Jetstream seeks to provide...
